Funded equally by LUNGevity Foundation and the National Lung Cancer Partnership
Michele Cote, PhD
Wayne State University, Karmanos Cancer Institute
Detroit
Dr. Cote is examining the role of estrogen-related tumor characteristics in predicting differences in survival between men and women after a lung cancer diagnosis. The identification of molecular and genetic profiles associated with survival will help target treatment advances and customize treatment for male and female lung cancer patients.